Advertisement

Topics

Human medicines European public assessment report (EPAR): Iasibon, ibandronic acid, Hypercalcemia,Fractures, Bone,Neoplasm Metastasis,Breast Neoplasms, Date of authorisation: 21/01/2011, Revision: 8, Status: Authorised

12:16 EDT 10 May 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Iasibon, ibandronic acid, Hypercalcemia,Fractures, Bone,Neoplasm Metastasis,Breast Neoplasms, Date of authorisation: 21/01/2011, Revision: 8, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Iasibon, ibandronic acid, Hypercalcemia,Fractures, Bone,Neoplasm Metastasis,Breast Neoplasms, Date of authorisation: 21/01/2011, Revision: 8, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Iasibon, ibandronic acid, Hypercalcemia,Fractures, Bone,Neoplasm Metastasis,Breast Neoplasms, Date of authorisation: 21/01/2011, Revision: 8, Status: Authorised"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Osteoporosis
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...